Dr. Lal PathLabs Limited (BOM:539524)
1,418.40
+20.50 (1.47%)
At close: Jan 22, 2026
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 230 billion as of January 23, 2026. Its market cap has decreased by -6.26% in one year.
Market Cap
230.00B
Enterprise Value
218.89B
Revenue
26.00B
Ranking
n/a
PE Ratio
43.03
Stock Price
1,418.40
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 230.00B, an increase of 237.33%. That is a compound annual growth rate of 12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 236.93B | -4.36% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thyrocare Technologies | 75.48B |
| One Global Service Provider | 9.32B |
| Chandan Healthcare | 6.30B |
| Star Imaging and Path Lab | 1.42B |
| Invicta Diagnostic | 830.38M |
| Aspira Pathlab & Diagnostics | 621.39M |
| Nidan Laboratories and Healthcare | 224.49M |
| Family Care Hospitals | 188.51M |